# Effect of Drospirenone-Ethinyl Estradiol (20microgram vs 30 Microgram) on Free Androgen Index in PCOS

> **NCT07318337** · NA · COMPLETED · sponsor: **Mst.Sumyara Khatun** · enrollment: 60 (actual)

## Conditions studied

- PCOS (Polycystic Ovary Syndrome)

## Interventions

- **DRUG:** Drospirenone Ethinyl Estradiol (20 microgram)
- **DRUG:** Drospirenone Ethinyl Estradiol (30 microgram)

## Key facts

- **NCT ID:** NCT07318337
- **Lead sponsor:** Mst.Sumyara Khatun
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-07-01
- **Primary completion:** 2025-06-30
- **Final completion:** 2025-06-30
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2026-01-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07318337

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07318337, "Effect of Drospirenone-Ethinyl Estradiol (20microgram vs 30 Microgram) on Free Androgen Index in PCOS". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07318337. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*